Global Empty Capsules Market Outlook, 2029

The Global Empty Capsules market is anticipated to exceed USD 5 Billion by 2029. Another factor driving the market is the increasing adoption of capsule-based drug delivery systems

The global empty capsules market is expected to witness significant growth. This growth is driven by several factors, including a rising demand for nutraceuticals, increased investment in capsule manufacturing in emerging countries, and a growing preference for capsules over other dosage forms. The key drivers of the market are the burgeoning nutraceutical industry. Nutraceuticals are products derived from food sources that provide health benefits, and capsules are a preferred mode of delivery for these products. The rising prevalence of chronic diseases such as diabetes and cancer, coupled with an increasing focus on personal health and wellness, is propelling the demand for nutraceutical. According to the research report, “Global Empty Capsules Market Outlook, 2029” published by Bonafide Research, the market is anticipated to cross USD 5 Billion by 2029. Another factor driving the market is the expansion of capsule manufacturing facilities in emerging countries. Pharmaceutical companies are increasingly investing in these regions, leading to the establishment of new manufacturing plants and a rise in production capacities for empty capsules. For instance, Qualicaps expanded its presence in the South Asia region, signifying a growing focus on emerging markets for capsule production. Similarly, This growth in production capabilities within emerging countries is expected to meet the rising global demand for empty capsules. Empty capsules offer several advantages over other dosage forms, such as easier swallowing, taste masking, and the ability to deliver a wider range of drugs and nutraceutical ingredients. These advantages are contributing to a growing preference for capsules among both patients and pharmaceutical companies. Advancements in capsule delivery technologies, such as the development of sustained-release and delayed-release capsules, are further propelling the market growth. The empty capsules market also faces some challenges. Stringent regulations in the pharmaceutical industry and ethical concerns regarding the use of animal-derived gelatin, which is a common material in capsule production, can potentially hamper market growth. Nevertheless, the growing demand for nutraceuticals, the expansion of manufacturing facilities in emerging countries, and the inherent advantages of capsules are expected to continue driving the global empty capsules market forward in the coming years.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market DriversRising Demand for Nutraceutical: Consumers are increasingly turning to nutraceuticals for health and wellness benefits. Capsules offer a convenient and effective delivery method for these products, particularly for ingredients with unpleasant taste or odor. The burgeoning nutraceutical market, valued at USD 185.2 billion in 2022 and projected to reach USD 261.7 billion by 2027 (CAGR 7.2%), directly translates to a growing demand for empty capsules . • Expansion of Capsule Manufacturing in Emerging Economies: Investment in pharmaceutical manufacturing is on the rise in emerging economies. This trend translates to the establishment of new empty capsule manufacturing facilities and increased production capacities. This not only caters to the growing local demand but also strengthens the global supply chain . • Technological Advancements in Capsule Delivery: The development of innovative capsule delivery technologies like sustained-release and delayed-release formulations is propelling market growth. These advancements enable targeted drug delivery, improved bioavailability, and enhanced patient compliance. Market Trends

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Shift towards Non-Gelatine Capsules: Ethical concerns regarding animal-derived gelatin and the growing vegan population are driving a trend towards non-gelatin capsules made from plant-based materials like hydroxypropyl methylcellulose (HPMC). This trend is expected to gain further traction in the coming years. • Focus on Sustainability: Sustainability is becoming a key concern across industries, and the empty capsule market is no exception. Manufacturers are increasingly focusing on eco-friendly capsule production processes and the use of biodegradable or bio-based materials to minimize environmental impact. • Customization and Functionality: The demand for customized empty capsules with specific functionalities like taste masking, color variations, and tamper-evident features is growing. This trend reflects the need for improved patient experience and brand differentiation within the pharmaceutical and nutraceutical sectors. Market ChallengesStringent Regulatory Landscape: The pharmaceutical industry is subject to stringent regulations regarding drug safety and quality. Empty capsule manufacturers need to comply with these regulations to ensure the safety and efficacy of their products. This can be a complex and costly process, potentially hindering market entry for new players. • Fluctuations in Raw Material Prices: The cost of raw materials, particularly gelatin, can fluctuate significantly due to factors like animal product prices and supply chain disruptions. This volatility can squeeze profit margins for capsule manufacturers and impact market stability. • Ethical Concerns and Cultural Restrictions: The use of animal-derived gelatin raises ethical concerns for some consumers, particularly vegetarians and vegans. Cultural restrictions in certain regions may limit the market potential for gelatin-based capsules.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

On the basis of the report, the type segment is segmented into Gelatin Capsules and Non-Gelatin Capsules. The Gelatin capsules lead in the Empty Capsules industry due to their versatility, widespread acceptance across pharmaceutical and nutraceutical sectors, and superior performance characteristics. Gelatin capsules have emerged as the predominant choice in the Empty Capsules industry for several compelling reasons that underscore their dominance in pharmaceutical and nutraceutical applications. These capsules are typically composed of gelatin derived from animal collagen, offering a versatile and reliable encapsulation solution for a wide range of active pharmaceutical ingredients (APIs) and dietary supplements. One of the primary reasons for the leadership of gelatin capsules is their proven track record of safety, compatibility, and performance in encapsulating both hydrophilic and hydrophobic substances. Gelatin's natural properties facilitate efficient dissolution and release of contents within the digestive tract, ensuring optimal bioavailability and efficacy of encapsulated medications and supplements. Gelatin capsules are recognized for their stability and compatibility with a diverse array of formulations, including sensitive compounds and complex drug delivery systems. Pharmaceutical manufacturers favor gelatin capsules for their ability to preserve the integrity of APIs, protect against moisture and oxygen ingress, and maintain product stability throughout shelf life. This reliability is critical in ensuring consistent drug delivery and patient compliance, particularly for medications requiring precise dosing and controlled release profiles. Another key factor driving the preference for gelatin capsules is their widespread acceptance and regulatory approval in global markets. Gelatin has a long history of use in pharmaceutical and dietary supplement industries, supported by comprehensive safety assessments and regulatory clearances from health authorities worldwide, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This regulatory compliance and established safety profile instill confidence among healthcare professionals, manufacturers, and consumers alike, contributing to the widespread adoption of gelatin capsules in both prescription and over-the-counter (OTC) products. gelatin capsules offer manufacturing advantages such as ease of formulation, efficient production processes, and compatibility with high-speed encapsulation equipment. These capsules can be manufactured in a variety of sizes, colors, and shapes to accommodate diverse product requirements and branding preferences. Pharmaceutical companies benefit from gelatin's mold ability and stability during production, allowing for precise filling of capsules with consistent weight and content uniformity, essential for quality assurance and compliance with pharmaceutical standards. On the basis of report, the therapeutic Application segment is segmented into Antibiotic & Antibacterial Drugs, Dietary Supplements and Other Therapeutic Applications. The Antibiotic & Antibacterial Drugs lead in the Empty Capsules industry due to precise dosage requirements, controlled release capabilities, and patient compliance in therapeutic applications. Antibiotic & Antibacterial Drugs have emerged as a leading segment in the Empty Capsules industry for several compelling reasons that highlight their critical role in pharmaceutical formulations requiring precise dosing, controlled release, and patient adherence. Empty capsules serve as versatile vehicles for encapsulating antibiotics and antibacterial medications, offering distinct advantages in terms of formulation flexibility and therapeutic efficacy. One of the primary reasons for the leadership of Antibiotic & Antibacterial Drugs in the Empty Capsules market is the critical need for accurate dosing and controlled release profiles in treating bacterial infections. Gelatin capsules, in particular, are well-suited for encapsulating antibiotics due to their ability to dissolve rapidly and release medication contents efficiently in the gastrointestinal tract, ensuring optimal absorption and therapeutic effect. Antibiotic and antibacterial formulations often require specific dosing regimens tailored to the severity of infection and patient response. Empty capsules provide pharmaceutical manufacturers with the flexibility to customize dosages by accurately filling capsules with precise amounts of active ingredients, facilitating standardized treatment protocols and adherence to therapeutic guidelines. This precision in dosing is essential for achieving therapeutic efficacy, minimizing drug resistance, and optimizing patient outcomes in the management of bacterial infections. Another key advantage of using empty capsules for antibiotic and antibacterial drugs lies in their ability to accommodate different release profiles, including immediate release, delayed release, and extended release formulations. Gelatin capsules can be formulated with coatings or fill materials that control the rate and location of drug release within the gastrointestinal tract, enhancing bioavailability and reducing potential side effects associated with rapid absorption. Controlled release formulations are particularly beneficial for antibiotics that require sustained blood levels over an extended period to effectively combat bacterial growth and prevent recurrence of infections. Patient compliance plays a crucial role in the success of antibiotic and antibacterial therapies. Gelatin capsules are preferred by healthcare providers and patients alike for their ease of swallowing, minimal taste interference, and compatibility with diverse patient populations, including pediatric and geriatric patients who may have difficulty swallowing tablets or unpleasant-tasting medications. The convenience and acceptability of capsules contribute to improved medication adherence, ensuring that patients complete their prescribed courses of antibiotics as directed by healthcare professionals, which is crucial for achieving therapeutic success and preventing antibiotic resistance. In addition to their therapeutic benefits, gelatin capsules used for antibiotic and antibacterial drugs are supported by stringent quality standards and regulatory approvals from health authorities worldwide. North America leads in the Empty Capsules industry due to its advanced pharmaceutical manufacturing capabilities, stringent quality standards, robust research and development infrastructure, and significant investment in healthcare innovation. North America has established itself as a global leader in the Empty Capsules industry, driven by several key factors that underscore its prominence in pharmaceutical and nutraceutical markets. The region encompasses the United States and Canada, both of which boast sophisticated pharmaceutical manufacturing capabilities, extensive regulatory frameworks, and a strong emphasis on technological innovation in healthcare. These factors collectively contribute to North America's leadership position in producing and supplying high-quality empty capsules that meet stringent global standards for safety, efficacy, and quality assurance. One of the primary reasons for North America's dominance in the Empty Capsules industry is its advanced pharmaceutical manufacturing capabilities. The region is home to leading pharmaceutical companies, contract manufacturing organizations (CMOs), and specialized capsule manufacturers equipped with state-of-the-art production facilities and automated encapsulation technologies. These facilities adhere to Good Manufacturing Practices (GMP) and stringent quality control measures mandated by regulatory authorities such as the US Food and Drug Administration (FDA) and Health Canada. This ensures that empty capsules produced in North America meet or exceed international standards for purity, stability, and uniformity, essential for pharmaceutical formulations ranging from prescription medications to dietary supplements. North America's robust regulatory environment plays a pivotal role in maintaining the highest standards of product safety and quality in the Empty Capsules industry. The FDA and Health Canada enforce rigorous guidelines for the approval, manufacturing, and marketing of pharmaceutical products, including empty capsules used as dosage forms. Manufacturers in the region must comply with these regulations, undergo regular inspections, and provide extensive documentation to demonstrate product efficacy and safety before commercialization. This regulatory compliance instills trust among global healthcare providers, pharmaceutical companies, and consumers, reinforcing North America's reputation as a reliable source of high-quality empty capsules. • In May 2022, Capsugel introduced a Titanium dioxide-free (TiO2-free) white hard gelatin capsule, catering to the European Union's regulations on titanium dioxide use in food products. o In March 2021, ACG launched the ACGcaps NTone and ACGcaps TSafe range of capsules specifically designed for the nutraceutical market. • In November 2021, ACG implemented a global nutraceutical campaign titled ""ACG loves nothing"" to promote problem-free nutraceutical production and highlight their commitment to developing high-quality capsules for both the pharmaceutical and nutraceutical industries. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Empty Capsules market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Type • Gelatin Capsules • Non-Gelatin Capsules By Functionality • Immediate-Release Capsules • Sustained-Release Capsules • Delayed-Release Capsules By End User • Pharmaceutical Manufacturers • Nutraceutical Manufacturers • Cosmetic Industry • Research Laboratories The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Empty Capsules industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

Request Table of Contents

First Name

Last Name

Company Name

Job Title

Business Email

Contact Number


Global Empty Capsules Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.